| Description |
1 online resource (347 p.) |
| Contents |
Cover -- Half-Title Page -- Series Page -- Title Page -- Copyright Page -- Contents -- Preface -- 1 Nanotechnology in Vaccine Development and Constraints -- 1.1 Introduction -- 1.2 Nanoparticles, an Alternative Approach to Conventional Vaccines -- 1.3 Nanoparticles as Vaccine Delivery Vehicle -- 1.4 Nanotechnology to Tackle the Challenges of Vaccine Delivery -- 1.4.1 Polymeric Nanoparticles -- 1.4.2 Inorganic Nanoparticles -- 1.4.3 Biomolecular Nanoparticles -- 1.4.4 Liposome -- 1.4.5 Virus-Like Particles -- 1.4.6 Micelles -- 1.4.7 Immunostimulating Complexes |
|
1.4.8 Self-Assembled Proteins (SAPNs) -- 1.4.9 Emulsions -- 1.5 Constraints and Challenges of Nanovaccines -- 1.6 Concluding Remarks -- Acknowledgments -- References -- 2 Nanomedicine and Nanovaccinology Tools in Targeted Drug Delivery -- 2.1 Introduction -- 2.2 Nanomaterial-Based Drug Delivery Tools -- 2.2.1 Inorganic Nanoparticles -- 2.2.2 Polymeric Nanoparticles -- 2.2.3 Dendrimers -- 2.2.4 Liposomes -- 2.2.5 Micelles -- 2.2.6 Emulsions -- 2.2.7 Carbon-Based Nanomaterials -- 2.2.8 Self-Assembled Proteins -- 2.2.9 Immunostimulating Complexes -- 2.2.10 Virus-Like Particles |
|
2.3 Targeted Drug Delivery Applications -- 2.3.1 Cancer -- 2.3.2 Neurology -- 2.3.3 Cardiology -- 2.3.4 Ophthalmology -- 2.3.5 Pulmonology -- 2.3.6 Tissue Engineering -- 2.3.7 Viral Infections -- 2.3.8 Other Miscellaneous Types -- 2.4 Commercial Nanodelivery Tools -- 2.4.1 Industrial Manufacturing -- 2.4.2 Advantages and Disadvantages -- 2.4.3 Risks and Challenges -- 2.5 Conclusions and Future Prospects -- Acknowledgments -- References -- 3 Nanovaccinology and Superbugs -- 3.1 Introduction -- 3.2 Need for Nanovaccines -- 3.3 Types of Nanovaccines -- 3.3.1 Subunit Vaccines |
|
3.3.2 Conjugate Vaccines -- 3.3.3 RNA Vaccines -- 3.3.4 Reverse Vaccinology -- 3.3.5 Biomimetic Nanovaccines -- 3.3.5.1 Biomimetic Membranes -- 3.3.5.2 Outer Membrane Vesicle Nanoparticles -- 3.3.6 Nanotoxoids -- 3.3.7 Liposomes -- 3.3.8 Polymeric Nanoparticles -- 3.3.9 Virus-Like Particle -- 3.3.10 Inorganic Nanoparticles -- 3.4 Mechanism of Action of Nanovaccines -- 3.5 Limitations of Nanovaccines -- 3.6 Conclusion -- Acknowledgment -- References -- 4 Current Research Trends on SARS-CoV2 Virus Against Nanovaccine Formulation -- 4.1 Introduction -- 4.2 COVID-19/SARS-CoV2 Pathophysiology |
|
4.3 Development of Nanovaccines Against SARS-CoV2 -- 4.4 Biomimetic Nanovaccines Against SARS-CoV2 -- 4.4.1 Virus-Like Particles -- 4.4.2 Nucleic Acids Vaccines -- 4.4.3 Protein Vaccines -- 4.5 Translatable Subunit Nanovaccine Against SARS-CoV2 -- 4.6 Separable Microneedle Patch Nanovaccine -- 4.7 Polymer-Based Nanovaccines -- 4.8 Pharmaceutical Challenges of SARS-CoV2 Nanovaccines -- 4.9 Future Prospects of SARS-CoV2 Nanovaccines -- 4.10 Challenges and Limitations -- 4.11 Conclusion and Outlook -- References -- 5 Nanovaccinology Against Infectious Disease -- 5.1 Introduction |
| Notes |
Description based upon print version of record |
|
5.2 Nanovaccinology Against Bacterial Disease |
| Subject |
Vaccines -- Technological innovations
|
|
Nanotechnology.
|
|
Nanotechnology.
|
|
Vaccines -- Technological innovations.
|
| Form |
Electronic book
|
| Author |
Pal, Kaushik, editor.
|
| ISBN |
1119858038 |
|
9781119858034 |
|
